Perrigo Co PLC
Chiusa
SettoreSettore sanitario
9.76 2.74
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
9.47
Massimo
9.82
Entrata | 1B -390M |
|---|---|
Vendite | -140M 969M |
EPS | 0.43 |
Rendimento da dividendi | 11.32 |
Margine di Profitto | -40.229 |
Dipendenti | 8,100 |
EBITDA | 962M -284M |
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | +79.14% upside |
Rendimento da dividendi Media del settore | 11.32% 2.41% |
|---|---|
Utili prossimi | 5 ago 2026 |
Prossima data del Dividendo | 15 set 2026 |
Prossima data del' Ex Dividendo | 28 ago 2026 |
Capitalizzazione di Mercato | -239M 1.3B |
|---|---|
Apertura precedente | 7.02 |
Chiusura precedente | 9.76 |
Notizie sul Sentiment di mercato
By Acuity
28%
72%
74 / 342 Classifica in Healthcare
Perrigo Co PLC Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Chi Siamo Perrigo Co PLC
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.